104 related articles for article (PubMed ID: 24437959)
1. [Glaucoma therapy - current overview of data and information].
Výborný P; Sičáková S; Dohnalová P; Feřtek M; Doležal T
Cesk Slov Oftalmol; 2013 Aug; 69(3):118-26. PubMed ID: 24437959
[TBL] [Abstract][Full Text] [Related]
2. Cost analysis of glaucoma medications.
Fiscella RG; Jensen MK
Am J Ophthalmol; 2008 Jun; 145(6):1108-9; author reply 1109. PubMed ID: 18503789
[No Abstract] [Full Text] [Related]
3. Glaucoma: optometry helps relieve the pressure.
Bullimore MA
Optom Vis Sci; 2002 Aug; 79(8):465-6. PubMed ID: 12199538
[No Abstract] [Full Text] [Related]
4. Comparative cost evaluation of brand name and generic ophthalmology medications in Ontario.
Popovic M; Chan C; Lattanzio N; El-Defrawy S; Schlenker MB
Can J Ophthalmol; 2018 Apr; 53(2):173-187. PubMed ID: 29631831
[TBL] [Abstract][Full Text] [Related]
5. Glaucoma medical treatment--2002: does yearly cost now equal the year?
Doyle JW; Smith MF; Tierney JW
Optom Vis Sci; 2002 Aug; 79(8):489-92. PubMed ID: 12199540
[TBL] [Abstract][Full Text] [Related]
6. Cost analysis of glaucoma medications.
Rylander NR; Vold SD
Am J Ophthalmol; 2008 Jan; 145(1):106-13. PubMed ID: 18154755
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
Kymes S
Am J Ophthalmol; 2006 Aug; 142(2):354; author reply 354-5. PubMed ID: 16876536
[No Abstract] [Full Text] [Related]
8. Dynamic view on affordability of fixed-dose combination antihypertensive drug therapy.
Hong SH; Wang J; Tang J
Am J Hypertens; 2013 Jul; 26(7):879-87. PubMed ID: 23512697
[TBL] [Abstract][Full Text] [Related]
9. Daily cost of glaucoma medications in China.
Gao Y; Wu L; Li A
J Glaucoma; 2007; 16(7):594-7. PubMed ID: 18091176
[TBL] [Abstract][Full Text] [Related]
10. Costs and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma: analysis conducted on the United Kingdom General Practitioner Research Database.
Lafuma A; Berdeaux G
Curr Med Res Opin; 2007 Dec; 23(12):3009-16. PubMed ID: 17958945
[TBL] [Abstract][Full Text] [Related]
11. Generic drug firm settles claim that it was paid to stay out of market.
Dyer O
BMJ; 2015 Apr; 350():h2282. PubMed ID: 25920419
[No Abstract] [Full Text] [Related]
12. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
Blumberg DM; Prager AJ; Liebmann JM
JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
[TBL] [Abstract][Full Text] [Related]
13. Financing new drug development in ophthalmology.
Novack GD
J Glaucoma; 2000 Apr; 9(2):195-9. PubMed ID: 10782633
[TBL] [Abstract][Full Text] [Related]
14. How prostaglandins have changed the medical approach to glaucoma and its costs: an observational study of 2228 patients treated with glaucoma medications.
De Natale R; Draghi E; Dorigo MT
Acta Ophthalmol Scand; 2004 Aug; 82(4):393-6. PubMed ID: 15291930
[TBL] [Abstract][Full Text] [Related]
15. Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma.
Queen JH; Feldman RM; Lee DA
Am J Ophthalmol; 2016 Mar; 163():70-74.e1. PubMed ID: 26596398
[TBL] [Abstract][Full Text] [Related]
16. Cost of selective laser trabeculoplasty vs topical medications for glaucoma.
Seider MI; Keenan JD; Han Y
Arch Ophthalmol; 2012 Apr; 130(4):529-30. PubMed ID: 22491929
[No Abstract] [Full Text] [Related]
17. Out-of-pocket costs to users: medicine options for hypertension.
Arredondo A
Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
[No Abstract] [Full Text] [Related]
18. [Mode of action, clinical profile and significance of beta-blockers in antiglaucoma therapy].
Schlote T
Klin Monbl Augenheilkd; 2013 Feb; 230(2):120-6. PubMed ID: 23430677
[TBL] [Abstract][Full Text] [Related]
19. Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs.
Schwartz GF; Tan J; Kotak S
J Ocul Pharmacol Ther; 2009 Dec; 25(6):555-61. PubMed ID: 20028264
[TBL] [Abstract][Full Text] [Related]
20. Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.
Goldberg LD; Walt J
Pharmacoeconomics; 2006; 24(3):251-64. PubMed ID: 16519547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
